<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">J. Neurol</journal-id><journal-title-group><journal-title>Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">0340-5354</issn><issn pub-type="epub">1432-1459</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4969887</article-id><article-id pub-id-type="publisher-id">5607</article-id><article-id pub-id-type="doi">10.1007/s00415-010-5607-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Kaji</surname><given-names>Ryuji</given-names></name><address><email>rkaji@clin.med.tokushima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Osako</surname><given-names>Yuka</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Suyama</surname><given-names>Kazuaki</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Toshio</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Uechi</surname><given-names>Yasuyuki</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Iwasaki</surname><given-names>Masaru</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Department of Clinical Neuroscience, Institute of Health Biosciences, Tokushima University Graduate School, 2-50-1 Kuramotocho, Tokushima, Tokushima 770-8503 Japan </aff><aff id="Aff2"><label>2</label>Japan Development and Medical Affairs Division, GlaxoSmithKline K.K., 4-6-15 Sendagaya, Shibuya-ku, Tokyo, 151-8566 Japan </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>6</month><year>2010</year></pub-date><pub-date pub-type="ppub"><year>2010</year></pub-date><volume>257</volume><fpage>1416</fpage><lpage>1416</lpage><permissions><copyright-statement>&#x000a9; Springer-Verlag 2010</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d30e81" ext-link-type="doi" xlink:href="10.1007/s00415-010-5526-3"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum to: J Neurol DOI 10.1007/s00415-010-5526-3</title><p>There was an error in the eligibility criteria in "Methods" section. Instead of:</p><p>&#x0201c;Patients</p><p>Male or female patients aged 20&#x02013;80&#x000a0;years and weighing at least 50&#x000a0;kg were eligible if they had had a stroke at least 6&#x000a0;months prior to treatment and had equinus deformity (plantar flexion of the ankle) as demonstrated by a score of&#x000a0;<bold>&#x0003e;3</bold> for ankle flexors on the Modified Ashworth Scale (MAS).&#x0201d;</p><p>It should read:</p><p>&#x0201c;Patients</p><p>Male or female patients aged 20&#x02013;80&#x000a0;years and weighing at least 50&#x000a0;kg were eligible if they had had a stroke at least 6&#x000a0;months prior to treatment and had equinus deformity (plantar flexion of the ankle) as demonstrated by a score of <bold>3 or 4</bold> for ankle flexors on the Modified Ashworth Scale (MAS).&#x0201d;</p></sec></body><back><fn-group><fn><p>On behalf of GSK1358820 Spasticity Study Group.</p></fn><fn><p>The online version of the original article can be found under doi:10.1007/s00415-010-5526-3.</p></fn></fn-group></back></article>